HanchorBio Inc. (TPE:7827)
Taiwan · Delayed Price · Currency is TWD 169.00
+3.50 (2.11%)
At close: Oct 8, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 23.66 billion as of October 9, 2026. It is the 12,187th most valuable company in the world and the 402nd biggest in Taiwan. Its market cap has increased by 180.07% in one year.
Market Cap
23.66B
Enterprise Value
22.18B
Revenue
321.77M
Global Rank
Country Rank
#402 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 23.66B, an increase of 328.54%. That is a compound annual growth rate of 205.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 23.66B | 105.47% |
| Dec 31, 2025 | 11.51B | 108.56% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 57.70B |
| A-Top Health Biotech | 37.03B |
| Elixiron Immunotherapeutics (Cayman) Limited | 20.28B |
| Obigen Pharma | 8.39B |
| Intelligene | 8.12B |
| Uwell Biopharma | 5.62B |
| Tripartite Therapeutics | 5.02B |
| Pet Pharm Biotech | 3.23B |